SCHEMBL5422425

SCHEMBL5422425

O=C(Cl)[C@H]1CC2CCC1CC2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.35
HSD11B1 P28845 1/20 0.34
P2RX7 Q99572 1/20 0.33
HPGD P15428 2/20 0.33
KCNQ3 O43525 1/20 0.33
KCNQ2 O43526 1/20 0.33
KCNQ4 P56696 1/20 0.33
KCNQ5 Q9NR82 1/20 0.33
MEN1 O00255 2/20 0.32
HTT P42858 2/20 0.32
KMT2A Q03164 2/20 0.32
GAA P10253 1/20 0.32
THRB P10828 1/20 0.32
NPC1 O15118 2/20 0.31
RAB9A P51151 2/20 0.31
KDM4E B2RXH2 1/20 0.31
EPHX2 P34913 1/20 0.31
HSD17B10 Q99714 1/20 0.30
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5724602 1.00 POLB (0.42) POLBL3MBTL1HSD11B1P2RX7HPGD
SCHEMBL5415108 1.00 POLB (0.42) POLBL3MBTL1HSD11B1P2RX7HPGD
SCHEMBL3759447 0.87 POLB (0.55) POLBL3MBTL1HSD11B1P2RX7HPGD
SCHEMBL3759450 0.87 POLB (0.55) POLBL3MBTL1HSD11B1P2RX7HPGD
SCHEMBL31244410 0.81
SCHEMBL23061770 0.79 SLC1A2 (0.42) POLBL3MBTL1HSD11B1HPGD
SCHEMBL5420877 0.79 SLC1A2 (0.42) POLBL3MBTL1HSD11B1HPGD
SCHEMBL3466009 0.79 SLC1A2 (0.42) POLBL3MBTL1HSD11B1HPGD
SCHEMBL16728466 0.79 SLC1A2 (0.42) POLBL3MBTL1HSD11B1HPGD
SCHEMBL5417560 0.79 SLC1A2 (0.42) POLBL3MBTL1HSD11B1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070135445-A1 Bicyclic Indolyl Derivatives and Methods for Their Use as Serotonergic Agents WYETH (US) 2007-06-14 US disclosed
US-7179813-B2 Bicyclic indolyl derivatives and methods for their use as serotonergic agents WYETH (US) 2007-02-20 US disclosed
US-20050124630-A1 Bicyclic indolyl derivatives and methods for their use as serotonergic agents WYETH (US) 2005-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135445-A1 Bicyclic Indolyl Derivatives and Methods for Their Use as Serotonergic Agents HTR4, HTR3A, TPH1 POLB 485/4885L3MBTL1 3859/4885HSD11B1 1467/4885
US-20050124630-A1 Bicyclic indolyl derivatives and methods for their use as serotonergic agents HTR4, HTR3A, TPH1 POLB 485/4885L3MBTL1 3859/4885HSD11B1 1467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.